Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 160

1.

Productive replication of Ebola virus is regulated by the c-Abl1 tyrosine kinase.

García M, Cooper A, Shi W, Bornmann W, Carrion R, Kalman D, Nabel GJ.

Sci Transl Med. 2012 Feb 29;4(123):123ra24. doi: 10.1126/scitranslmed.3003500.

2.

Regulation of Ebola virus VP40 matrix protein by SUMO.

Baz-Martínez M, El Motiam A, Ruibal P, Condezo GN, de la Cruz-Herrera CF, Lang V, Collado M, San Martín C, Rodríguez MS, Muñoz-Fontela C, Rivas C.

Sci Rep. 2016 Nov 16;6:37258. doi: 10.1038/srep37258.

3.

Suppressor of Cytokine Signaling 3 Is an Inducible Host Factor That Regulates Virus Egress during Ebola Virus Infection.

Okumura A, Rasmussen AL, Halfmann P, Feldmann F, Yoshimura A, Feldmann H, Kawaoka Y, Harty RN, Katze MG.

J Virol. 2015 Oct;89(20):10399-406. doi: 10.1128/JVI.01736-15. Epub 2015 Aug 5.

4.
5.

Ubiquitin Ligase WWP1 Interacts with Ebola Virus VP40 To Regulate Egress.

Han Z, Sagum CA, Takizawa F, Ruthel G, Berry CT, Kong J, Sunyer JO, Freedman BD, Bedford MT, Sidhu SS, Sudol M, Harty RN.

J Virol. 2017 Sep 27;91(20). pii: e00812-17. doi: 10.1128/JVI.00812-17. Print 2017 Oct 15.

6.

Molecular determinants of Ebola virus virulence in mice.

Ebihara H, Takada A, Kobasa D, Jones S, Neumann G, Theriault S, Bray M, Feldmann H, Kawaoka Y.

PLoS Pathog. 2006 Jul;2(7):e73.

7.

The spatio-temporal distribution dynamics of Ebola virus proteins and RNA in infected cells.

Nanbo A, Watanabe S, Halfmann P, Kawaoka Y.

Sci Rep. 2013;3:1206. doi: 10.1038/srep01206. Epub 2013 Feb 4.

8.

ALIX Rescues Budding of a Double PTAP/PPEY L-Domain Deletion Mutant of Ebola VP40: A Role for ALIX in Ebola Virus Egress.

Han Z, Madara JJ, Liu Y, Liu W, Ruthel G, Freedman BD, Harty RN.

J Infect Dis. 2015 Oct 1;212 Suppl 2:S138-45. doi: 10.1093/infdis/jiu838. Epub 2015 Mar 18.

9.

Cyanovirin-N binds to the viral surface glycoprotein, GP1,2 and inhibits infectivity of Ebola virus.

Barrientos LG, O'Keefe BR, Bray M, Sanchez A, Gronenborn AM, Boyd MR.

Antiviral Res. 2003 Mar;58(1):47-56.

PMID:
12719006
10.

Virtual screening of the inhibitors targeting at the viral protein 40 of Ebola virus.

Karthick V, Nagasundaram N, Doss CG, Chakraborty C, Siva R, Lu A, Zhang G, Zhu H.

Infect Dis Poverty. 2016 Feb 17;5:12. doi: 10.1186/s40249-016-0105-1.

11.

Vesicular release of ebola virus matrix protein VP40.

Timmins J, Scianimanico S, Schoehn G, Weissenhorn W.

Virology. 2001 Apr 25;283(1):1-6.

12.

Conserved motifs within Ebola and Marburg virus VP40 proteins are important for stability, localization, and subsequent budding of virus-like particles.

Liu Y, Cocka L, Okumura A, Zhang YA, Sunyer JO, Harty RN.

J Virol. 2010 Mar;84(5):2294-303. doi: 10.1128/JVI.02034-09. Epub 2009 Dec 23.

13.

ISG15 inhibits Ebola VP40 VLP budding in an L-domain-dependent manner by blocking Nedd4 ligase activity.

Okumura A, Pitha PM, Harty RN.

Proc Natl Acad Sci U S A. 2008 Mar 11;105(10):3974-9. doi: 10.1073/pnas.0710629105. Epub 2008 Feb 27.

15.

A novel life cycle modeling system for Ebola virus shows a genome length-dependent role of VP24 in virus infectivity.

Watt A, Moukambi F, Banadyga L, Groseth A, Callison J, Herwig A, Ebihara H, Feldmann H, Hoenen T.

J Virol. 2014 Sep;88(18):10511-24. doi: 10.1128/JVI.01272-14. Epub 2014 Jun 25.

16.

Unconventional secretion of Ebola virus matrix protein VP40.

Reynard O, Reid SP, Page A, Mateo M, Alazard-Dany N, Raoul H, Basler CF, Volchkov VE.

J Infect Dis. 2011 Nov;204 Suppl 3:S833-9. doi: 10.1093/infdis/jir305.

17.

VP40 octamers are essential for Ebola virus replication.

Hoenen T, Volchkov V, Kolesnikova L, Mittler E, Timmins J, Ottmann M, Reynard O, Becker S, Weissenhorn W.

J Virol. 2005 Feb;79(3):1898-905.

18.

In vivo oligomerization and raft localization of Ebola virus protein VP40 during vesicular budding.

Panchal RG, Ruthel G, Kenny TA, Kallstrom GH, Lane D, Badie SS, Li L, Bavari S, Aman MJ.

Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15936-41. Epub 2003 Dec 12.

19.
20.

Ebola virus VP40 drives the formation of virus-like filamentous particles along with GP.

Noda T, Sagara H, Suzuki E, Takada A, Kida H, Kawaoka Y.

J Virol. 2002 May;76(10):4855-65.

Supplemental Content

Support Center